Compass Therapeutics, Inc. (CMPX)

NCM – Real vaqt narxi. Valyuta: USD

5.21

-0.12 (-2.25%)

Yopilishda: Mar 27, 2026, 4:00 PM EDT

5.29

+0.08 (1.54%)

Bozordan keyin: Mar 27, 2026, 6:39 PM EDT

Compass Therapeutics, Inc.

MamlakatQo'shma Shtatlar

SanoatBiotexnologiya

SektorSalomatlikni saqlash

IPO sanasiN/A

Ijrochi bosh direktorThomas Schuetz

Kompaniya haqida

Compass Therapeutics, Inc., klinik bosqichdagi onkologiyaga yo'naltirilgan biofarmatsevtika kompaniyasi, Qo'shma Shtatlarda turli inson kasalliklarini davolash uchun antitelaga asoslangan terapevtik vositalarni ishlab chiqadi. Kompaniyaning etakchi dori nomzodi, tovecimig, delta-o'xshash ligand 4 (DLL4) va qon tomirlar endotelial o'sish omili A (VEGF-A) ga yo'naltirilgan bispesifik antiteladir, ular angiogenez va o'simta qon tomirlari uchun muhimdir. Kompaniya shuningdek, immunitet hujayralaridagi muhim ko'stimulyatsion retseptor bo'lgan CD137 agonisti CTX-471, IgG4 monoklonal antitelasi; dasturlashgan hujayra o'limi oqsili-1 (PD-1) va ligand PD-L1 nazorat nuqtasi ingibitori antitelalariga yo'naltirilgan bispesifik ingibitor CTX-8371; va PD-1 va VEFG-A ga yo'naltirilgan bispesifik antitelaning CTX-10726ni ishlab chiqadi. Kompaniya 2014 yilda tashkil etilgan va shtab-kvartirasi Massachusets shtatining Boston shahrida joylashgan.

Asosiy rahbarlar

Ism	Lavozim
Anna Gifford	Communications Manager
Dr. Cynthia A. Sirard M.D.	Chief Medical Officer
Dr. James Kranz Ph.D.	VP and Head of Chemistry Manufacturing & Controls
Dr. Thomas J. Schuetz M.D., Ph.D.	CEO & Vice Chairman
Mr. Arjun Prasad M.B.A., M.P.H.	Chief Commercial Officer
Mr. Barry Shin J.D., M.B.A.	Chief Financial Officer
Mr. Bing Gong Ph.D.	Chief Scientific Officer

Compass Therapeutics, Inc.

MamlakatQo'shma Shtatlar

SanoatBiotexnologiya

SektorSalomatlikni saqlash

IPO sanasiN/A

Ijrochi bosh direktorThomas Schuetz

Aloqa ma’lumotlari

Manzil:80 Guest Street, Suite 601, Boston, Massachusetts 02135, Qo'shma Shtatlar

Telefon:617 500 8099

Veb-sayt:https://www.compasstherapeutic...

Aksiya ma’lumotlari

So‘nggi SEC hisobotlari

Sana	Turi	Hujjat
2026-03-12	S-8	d110919ds8.htm
2026-03-05	10-K	cmpx20251231_10k.htm
2026-01-06	8-K	f8k_010626.htm
2025-12-31	DEL AM	d26360ddelam.htm
2025-12-30	S-3	d26360ds3.htm
2025-11-05	10-Q	cmpx20250930_10q.htm
2025-08-13	8-K	d153873d8k.htm
2025-08-11	8-K	f8k_080925.htm
2025-06-12	8-K	f8k_061225.htm
2025-05-08	8-K	f8k_050725.htm

Kompaniya haqida

Asosiy rahbarlar

Ism	Lavozim
Anna Gifford	Communications Manager
Dr. Cynthia A. Sirard M.D.	Chief Medical Officer
Dr. James Kranz Ph.D.	VP and Head of Chemistry Manufacturing & Controls
Dr. Thomas J. Schuetz M.D., Ph.D.	CEO & Vice Chairman
Mr. Arjun Prasad M.B.A., M.P.H.	Chief Commercial Officer
Mr. Barry Shin J.D., M.B.A.	Chief Financial Officer
Mr. Bing Gong Ph.D.	Chief Scientific Officer